C T Eliopoulos

615 total citations
8 papers, 507 citations indexed

About

C T Eliopoulos is a scholar working on Infectious Diseases, Molecular Medicine and Pharmacology. According to data from OpenAlex, C T Eliopoulos has authored 8 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Molecular Medicine and 4 papers in Pharmacology. Recurrent topics in C T Eliopoulos's work include Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). C T Eliopoulos is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). C T Eliopoulos collaborates with scholars based in United States and Israel. C T Eliopoulos's co-authors include George M. Eliopoulos, R C Moellering, George Sakoulas, Jeff Alder, Mary Jane Ferraro, Louis B. Rice, Sandra Willey, R. Hindes, Barbara E. Murray and Robert C. Moellering and has published in prestigious journals such as Clinical Microbiology Reviews, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

C T Eliopoulos

8 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C T Eliopoulos United States 8 272 189 178 177 171 8 507
C Thauvin-Eliopoulos United States 12 464 1.7× 171 0.9× 149 0.8× 275 1.6× 161 0.9× 17 653
Mary S. Barrett United States 13 167 0.6× 163 0.9× 226 1.3× 84 0.5× 232 1.4× 31 473
P. Hohl Switzerland 11 271 1.0× 232 1.2× 260 1.5× 97 0.5× 231 1.4× 26 578
Elizabeth Gradelski United States 13 135 0.5× 260 1.4× 261 1.5× 118 0.7× 129 0.8× 19 513
Patti M. Raney United States 11 236 0.9× 356 1.9× 105 0.6× 205 1.2× 145 0.8× 13 651
Irene Yu Lubenko United States 10 225 0.8× 296 1.6× 356 2.0× 127 0.7× 155 0.9× 20 538
Toyoko Oguri Japan 15 349 1.3× 115 0.6× 95 0.5× 135 0.8× 229 1.3× 85 626
M S Barrett United States 11 238 0.9× 107 0.6× 76 0.4× 125 0.7× 121 0.7× 18 416
E Huczko United States 15 317 1.2× 273 1.4× 345 1.9× 86 0.5× 356 2.1× 20 806
Laurel S. Almer United States 9 207 0.8× 196 1.0× 200 1.1× 86 0.5× 249 1.5× 10 482

Countries citing papers authored by C T Eliopoulos

Since Specialization
Citations

This map shows the geographic impact of C T Eliopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C T Eliopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C T Eliopoulos more than expected).

Fields of papers citing papers by C T Eliopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C T Eliopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C T Eliopoulos. The network helps show where C T Eliopoulos may publish in the future.

Co-authorship network of co-authors of C T Eliopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of C T Eliopoulos. A scholar is included among the top collaborators of C T Eliopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C T Eliopoulos. C T Eliopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Sakoulas, George, George M. Eliopoulos, Jeff Alder, & C T Eliopoulos. (2003). Efficacy of Daptomycin in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 47(5). 1714–1718. 117 indexed citations
2.
Malanoski, G J, L A Collins, C T Eliopoulos, Robert C. Moellering, & George M. Eliopoulos. (1995). Comparative in vitro activities of L-695,256, a novel carbapenem, against gram-positive bacteria. Antimicrobial Agents and Chemotherapy. 39(4). 990–995. 11 indexed citations
3.
Cercenado, Emilia, Serhat Ünal, C T Eliopoulos, et al.. (1995). Characterization of vancomycin resistance in Enterococcus durans. Journal of Antimicrobial Chemotherapy. 36(5). 821–825. 14 indexed citations
4.
Eliopoulos, George M., et al.. (1993). In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria. Antimicrobial Agents and Chemotherapy. 37(2). 366–370. 117 indexed citations
5.
Rice, Louis B., C T Eliopoulos, Joseph D. Yao, George M. Eliopoulos, & Robert C. Moellering. (1992). In vivo activity of the combination of daptomycin and fosfomycin compared with daptomycin alone against a strain of Enterococcus faecalis with high-level gentamicin resistance in the rat endocarditis model. Diagnostic Microbiology and Infectious Disease. 15(2). 173–176. 20 indexed citations
6.
Eliopoulos, George M. & C T Eliopoulos. (1990). Therapy of enterococcal infections. European Journal of Clinical Microbiology & Infectious Diseases. 9(2). 118–126. 39 indexed citations
7.
Hindes, R., Sandra Willey, George M. Eliopoulos, et al.. (1989). Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin. Antimicrobial Agents and Chemotherapy. 33(7). 1019–1022. 46 indexed citations
8.
Eliopoulos, George M. & C T Eliopoulos. (1988). Antibiotic combinations: should they be tested?. Clinical Microbiology Reviews. 1(2). 139–156. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Thauvin-Eliopoulos Breakdown of academic impact, for papers by Mary S. Barrett Breakdown of academic impact, for papers by P. Hohl Breakdown of academic impact, for papers by Elizabeth Gradelski Breakdown of academic impact, for papers by Patti M. Raney Breakdown of academic impact, for papers by Irene Yu Lubenko Breakdown of academic impact, for papers by Toyoko Oguri Breakdown of academic impact, for papers by M S Barrett Breakdown of academic impact, for papers by E Huczko Breakdown of academic impact, for papers by Laurel S. Almer
Rankless by CCL
2026